<< Start < Next > End >>

Page 127 of 3

Newsletter

BioMedReports U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks... http://t.co/32TdXZ0uSX
4hreplyretweetfavorite
BioMedReports Aratana Therapeutics Inc (NASDAQ:PETX) Hits 5-Month High On Positive development: After the announcement of p... http://t.co/xsLwjGgVSe
BioMedReports Doug Loe: Canada Has Earned Its Spot in the Biotech All-Star Team Photo: Biotech investors in the United State... http://t.co/TQiDczlMjS
Benzinga.com supporter Seeking Alpha Certified